Evidence map›Paper›PMID 38182580›Full record

ArticleNature communications2024

Nuclear Hsp104 safeguards the dormant translation machinery during quiescence.

Verena Kohler, Andreas Kohler, Lisa Larsson Berglund, Xinxin Hao, Sarah Gersing, Axel Imhof, Thomas Nyström, Johanna L Höög, Martin Ott, Claes Andréasson and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Proteostasis and ageing dissidence.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. The role of the nucleus in the control of mitochondrial precursor proteins in yeast.Protein science : a publication of the Protein Society · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Verena KohlerDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 10691, Stockholm, Sweden.ORCID 0000-0002-1241-162X
Andreas KohlerInstitute of Molecular Biosciences, University of Graz, 8010, Graz, Austria.ORCID 0000-0001-6571-2162
Lisa Larsson BerglundDepartment of Chemistry and Molecular Biology, University of Gothenburg, 40530, Gothenburg, Sweden.
Xinxin HaoDepartment of Microbiology and Immunology, University of Gothenburg, 40530, Gothenburg, Sweden.ORCID 0000-0001-5758-6290
Sarah GersingThe Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, 1165, Copenhagen, Denmark.
Axel ImhofBiomedical Center Munich, Faculty of Medicine, Ludwig Maximilian University of Munich, 82152, Planegg-Martinsried, Germany.ORCID 0000-0003-2993-8249
Thomas NyströmDepartment of Microbiology and Immunology, University of Gothenburg, 40530, Gothenburg, Sweden.ORCID 0000-0001-5489-2903
Johanna L HöögDepartment of Chemistry and Molecular Biology, University of Gothenburg, 40530, Gothenburg, Sweden.ORCID 0000-0003-2162-3816
Martin OttDepartment of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden.
Claes AndréassonDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 10691, Stockholm, Sweden. claes.andreasson@su.se.ORCID 0000-0001-8948-0685
Sabrina BüttnerDepartment of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 10691, Stockholm, Sweden. sabrina.buettner@su.se.ORCID 0000-0002-2786-8542
University of Gothenburg · SEStockholm University · SEUniversity of Graz · ATLudwig-Maximilians-Universität München · DEUniversity of Copenhagen · DK

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) J4342-B21Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) J4398-BAustrian Science Fund FWF J 4342Austrian Science Fund FWF J 4398Cancerfonden (Swedish Cancer Society) 201045Cancerfonden (Swedish Cancer Society) 211865Cancerfonden (Swedish Cancer Society) 222488Deutsche Forschungsgemeinschaft (German Research Foundation) 213249687Deutsche Forschungsgemeinschaft (German Research Foundation) 325871075Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2017.009Stiftelsen Olle Engkvist Byggmästare 207-0527Vetenskapsrådet (Swedish Research Council) 2019-04004Vetenskapsrådet (Swedish Research Council) 2019-04052Vetenskapsrådet (Swedish Research Council) 2019-05249
6 · The paper itself

Abstract

The resilience of cellular proteostasis declines with age, which drives protein aggregation and compromises viability. The nucleus has emerged as a key quality control compartment that handles misfolded proteins produced by the cytosolic protein biosynthesis system. Here, we find that age-associated metabolic cues target the yeast protein disaggregase Hsp104 to the nucleus to maintain a functional nuclear proteome during quiescence. The switch to respiratory metabolism and the accompanying decrease in translation rates direct cytosolic Hsp104 to the nucleus to interact with latent translation initiation factor eIF2 and to suppress protein aggregation. Hindering Hsp104 from entering the nucleus in quiescent cells results in delayed re-entry into the cell cycle due to compromised resumption of protein synthesis. In sum, we report that cytosolic-nuclear partitioning of the Hsp104 disaggregase is a critical mechanism to protect the latent protein synthesis machinery during quiescence in yeast, ensuring the rapid restart of translation once nutrients are replenished.

Indexed as

Heat-Shock ProteinsProtein BiosynthesisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell CycleCell DivisionCytosolProtein AggregatesHeat-Shock ProteinsHsP104 protein, S cerevisiaeProtein AggregatesSaccharomyces cerevisiae Proteins

Identifiers

PMID38182580
PMCPMC10770042
OpenAlexW4390616837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.